Goeteyn, Ellen
Taylor, Steven L.
Dicker, Alison
Bollé, Laura
Wauters, Merel
Joossens, Marie
Van Braeckel, Eva
Simpson, Jodie L.
Burr, Lucy
Chalmers, James D.
Rogers, Geraint B.
Crabbé, Aurélie
Funding for this research was provided by:
Research Foundation Flanders (1S34622N)
National Health and Medical Research Council (APP2008625)
Fonds Wetenschappelijk Onderzoek (G024423N, 1SC3722N)
Ghent University Industrial Research Fund (F2020/IOF-StarTT/103)
Article History
Received: 24 January 2024
Accepted: 18 September 2024
First Online: 12 October 2024
Declarations
:
: The Aus-asthma cohort received ethics approval ACTRN12609000197235 (registration date 20/04/2009) by the Hunter New England human research ethics committee. The Aus-bx cohort received ethics approval ACTRN12608000460303 (registration date 14/07/2009) by the Mater Health Service human research ethics committee. The Scot-bx cohort received ethics approval 12/ES/0059 by the East of Scotland Research Ethics committee. For Aus-asthma, the Human ethics and consent to participate was provided by the Hunter New England human research ethics committee. For Aus-bx, the Human ethics and consent to participate was provided by the Mater Health Service human research ethics committee. For Scot-bx, patients gave written informed consent and the study was approved by the East of Scotland Research Ethics committee (12/ES/0059).
: Not applicable.
: The authors declare no competing interests.